Stay updated on BI 695501 vs Adalimumab in Active RA Clinical Trial
Sign up to get notified when there's something new on the BI 695501 vs Adalimumab in Active RA Clinical Trial page.

Latest updates to the BI 695501 vs Adalimumab in Active RA Clinical Trial page
- Check5 days agoChange DetectedRevision v3.3.4 was added and revision v3.3.3 was removed. This is a minor housekeeping update to the page's revision history.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a comprehensive Locations section listing trial sites by state (e.g., AL, AZ, CA, CO, FL, etc.). Updated revision to v3.3.3 and removed v3.3.2/HHS Vulnerability Disclosure.SummaryDifference1%

- Check55 days agoChange DetectedAdded note that publications are automatically filled from PubMed and may not be about the study, and updated the revision to v3.3.2. Removed the older statement that publications come from PubMed and are automatically created by ClinicalTrials.gov Identifier (NCT Number); to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedThe funding-status notice banner about government funding lapses has been removed from the page, removing an administrative alert unrelated to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check77 days agoChange DetectedNo significant changes were detected in the Study Details page; only minor formatting and layout adjustments were observed that do not affect the core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check105 days agoChange DetectedThe page now includes an operating-status notice and a version update to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference2%

Stay in the know with updates to BI 695501 vs Adalimumab in Active RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 695501 vs Adalimumab in Active RA Clinical Trial page.